New stock news | Hong Kong and Macao culture and tourism delivered to the Hong Kong Stock Exchange
According to the Hong Kong Stock Exchange disclosure on May 20th, China Travel Hong Kong and Macau Cultural Tourism Holdings Limited (referred to as Hong Kong and Macao Cultural Tourism) submitted an application for listing on the Main Board of the Hong Kong Stock Exchange through introduction. China Galaxy Securities is its exclusive sponsor.
According to the disclosure of the Hong Kong Stock Exchange on May 20th, China Travel Hong Kong and Macao Cultural Tourism Holdings Limited (referred to as Hong Kong and Macao Cultural Tourism) has submitted an application for listing on the main board of the Hong Kong Stock Exchange in an introduction manner, with China Galaxy Securities as its exclusive sponsor. The prospectus shows that Hong Kong and Macao Cultural Tourism is a leading integrated tourism service provider with a strategic focus on the Greater Bay Area, operating a comprehensive cross-border passenger transport platform covering sea and land routes in the Greater Bay Area. The company provides cross-border transportation services through two major cross-border passenger transport brands: "Jet Speed Flying" and "China Travel Bus". In addition, the company operates three distinctive hotel brands (Regal, Rosedale, and Banyan Tree) with prime locations in key commercial areas and tourist hotspots in Hong Kong, Macao, and Beijing.
Related Articles
DEEPEXI TECH (01384) plans to discount approximately 19.78% of the placement of 7.942 million new H shares, raising approximately HK$395 million net.
JENSCARE-B(09877): The 12-month clinical follow-up results of patients with large valve disease who received the LuX-Valve Plus EU TRINITY research will be released at EuroPCR 2026, demonstrating the advantages of the product's large size.
New stock news | Zoomlion Heavy Industry submits an application to the Hong Kong Stock Exchange again as a mining equipment and aerial work equipment company.
DEEPEXI TECH (01384) plans to discount approximately 19.78% of the placement of 7.942 million new H shares, raising approximately HK$395 million net.
JENSCARE-B(09877): The 12-month clinical follow-up results of patients with large valve disease who received the LuX-Valve Plus EU TRINITY research will be released at EuroPCR 2026, demonstrating the advantages of the product's large size.
New stock news | Zoomlion Heavy Industry submits an application to the Hong Kong Stock Exchange again as a mining equipment and aerial work equipment company.
